Significant Ownership of Leonite Fund I, LP
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Leonite Fund I, LP focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- Avi Geller - Chief Investment Officer
- Manager location
- Spring Valley, NY
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Leonite Fund I, LP and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
CIK context first
Continue from Leonite Fund I, LP
Significant Ownership of Leonite Fund I, LP
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| MEHA | Functional Brands Inc. | Common Shares, $0.00001 par value per share | 8.8% | $412,096 | 2,289,424 | Leonite Fund I, LP | 04 May 2026 | ||
| RSLS | ReShape Lifesciences Inc. | Common Shares, $0.001 par value per share | 6.1% | $76,000 | 200,000 | Leonite Fund I, LP | 18 Feb 2025 | ||
| HSDT | HELIUS MEDICAL TECHNOLOGIES, INC. | Common Shares, $0.001 par value per share | 5.2% | $699,506 | 163,055 | Leonite Fund I, LP | 05 Jun 2025 |
Schedules 13D/G Reported by Leonite Fund I, LP:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.